The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world treatment patterns and clinical outcomes for patients with deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC).
 
Vanessa Wong
Speakers' Bureau - Merck; Novartis; SERVIER
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); SERVIER (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Merck
 
Grace Kim
No Relationships to Disclose
 
Matthew Loft
No Relationships to Disclose
 
Belinda Lee
Honoraria - Roche
Research Funding - AngioDynamics (Inst); Servier (Inst); Specialised Therapeutics (Inst)
Travel, Accommodations, Expenses - Ipsen; Roche
 
Rachel Wong
Honoraria - Astellas Pharma; MSD
Consulting or Advisory Role - Bristol Meyers Squibb; MSD; MSD; MSD
Travel, Accommodations, Expenses - AstraZeneca; MSD; MSD
 
Geoffrey Chong
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene (Inst); Regeneron (Inst); Takeda (Inst)
Speakers' Bureau - Takeda (Inst)
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dizal Pharma (Inst); Dizal Pharma (Inst); Eikon Therapeutics (Inst); Incyte (Inst); Innate Pharma (Inst); Merck Serono (Inst); MorphoSys (Inst); Regeneron (Inst); Roche (Inst); Seagen (Inst)
 
Azim Jalali
No Relationships to Disclose
 
Mun Sem Liew
No Relationships to Disclose
 
Natalie Rainey
Honoraria - AstraZeneca; Gilead Sciences
Other Relationship - Novartis
 
Matthew Burge
No Relationships to Disclose
 
Theresa Hayes
No Relationships to Disclose
 
Niall Tebbutt
Honoraria - Astellas Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; Merck; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; Bristol Myers Squibb Foundation; Merck; Takeda
Expert Testimony - Astellas Pharma
 
Sue-Anne McLachlan
Honoraria - BMS Australia
Consulting or Advisory Role - BeiGene; Bristol-Myers Squibb
 
Hiren Mandaliya
No Relationships to Disclose
 
Sarah Sutherland
No Relationships to Disclose
 
Shu Fen Wong
No Relationships to Disclose
 
Stephanie Lim
Consulting or Advisory Role - MSD
Speakers' Bureau - AstraZeneca
 
Louise Nott
Honoraria - Amgen (Inst); Merck Serono; Merck Sharp & Dohme
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bristol Myers Squibb Foundation; Novartis; Roche
 
Ayesha Saqib
No Relationships to Disclose
 
Peter Gibbs
Honoraria - Bristol-Myers Squibb/Sanofi; Merck; MSD Oncology; Pierre Fabre; SERVIER
Consulting or Advisory Role - Haystack Oncology
Research Funding - Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb/Sanofi (Inst); GRAIL (Inst); Haystack Oncology (Inst); Merck Serono (Inst); Pierre Fabre (Inst); Roche (Inst); Servier (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Servier